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Summary: Five different methods for the determination of 3-methoxy-4-hydroxymandelic acid (vanilmandel-
ic acid, VMA) in urine were compared: a GLC-FID catecholamine metabolite profiling method, an HPLC
method with electrochemical detection, the method of Pisano et al. ((1962) Clin. Chim. Acta 7, 285—291), a
one dimensional paper Chromatographie method with diazotized p-nitroaniJine staining and the commercially
available Bio-Rad VMA by Column Test. The comparison consisted of an imprecision study, a linearity
check, a recovery study, a split sample comparison and an interference study. The best results of the impreci-
sion study (n = 8) were found with the Bio-Rad and the HPLC method (within-run imprecision had a coeffi-
cient of Variation (CV) of 5.1% and 1.4%; between-days CV of 5.9% and 6.0% respectively for values of
32.4 μπιοΐ/ΐ and 24.5 μπιοΙ/1). The Pisano method had the poorest within-run CV (14.6%) and between-days
CV (16.8%) for a value of 23.2 μΐηοΐ/ΐ. All methods showed good linearity. The mean recovery of the HPLC
method was 101.3%; the mean recovery of the other four methods ranged from 93.9%—96.0%. The split
sample comparison showed that the accuracy of the HPLC, the GLC and the Pisano method is comparable.
The accuracy of the paper Chromatographie method and the Bio-Rad method had a positive bias compared
with the HPLC method. Especially the positive bias of the Bio-Rad method can be very large. The HPLC
method was not influenced by the compounds tested in the interference study, whereas the GLC method in
some cases only suffered from overloading problems. The Pisano and the Bio-Rad method were most influ-
enced by the interfering compounds tested. We conclude that the HPLC and the GLC methods are superior to
the other three VMA methods. From an analytical point of view HPLC is the method of choice for determin-
ing 3-methoxy-4-hydroxymandelic acid in urine.
Vergleichende Untersuchung von f nf verschiedenen Methoden zur Bestimmung von 3-Methoxy-4-hydroxy-
mandels ure im Harn
Zusammenfassung:
F nf verschiedene Methoden zur Bestimmung von 3-Methoxy-4-hydroxymandels ure (Vanillinmandels ure,
VMA) im Harn werden verglichen:
1. Gaschromatographische Methode mit Flammenionisations-Detektion zur Erstellung von Catecholamin-
metabolit-Profiien.
!) Present adress: Algerneen Ziekenhuis "de Tjongersscfaans", Thialfweg 44, NL-844I PW Heereiiveeru The Nctherlands.
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2. Hochleistungsfl ssigchromatographische (HPLC) Methode mit elektrochemischer Detektion.
3. Methode nach Pisano ((1962) Clin. Chim. Acta 7, 285-291).
4. Eindimensionale papierchromatographische Methode mit Detektion durch diaz tiertes p-Nitroanilin.
5. S ulen-Test Βίο-Rad VMA. .
 f
Der Vergleich umfa te:
a) Untersuchungen zur Pr zision (n = 8)
Die besten Ergebnisse wurden mit der Bio-Rad und der HPLC-Methode erzielt: VK in der Serie 5-,l% und
l ,4%; VK von Tag zu Tag 5,9% und 6,0%; c = 32,4 und 24,5 μπιοΐ/ΐ. Die Pisano-Methode hatte die schlech-
teste Pr zision: VK in der Serie 14,6%; VK von Tag zu Tag 16,8%; c = 23,2 μπιοΐ/ΐ
b) Linearit tspr fung
Alle Methoden wiesen eine gute Linearit t auf.
c) Untersuchungen zur Wiederfindung
Die mittlere Wiederfindung der HPLC-Methode betrug 101,3%, die der anderen 4 Methoden 93,9-96,0%.
d) Pr fung der Richtigkeit durch Vergleich an der geteilten Probe
Die Richtigkeit von HPLC-, gaschromatographischer und Fwano-Methode ist vergleichbar. Papierchromato-
graphische und Bio-Rad-Methode zeigten, verglichen mit der HPLC-Methode, eine positive Abweichung, die
besonders bei der Bio-Rad-Methode sehr hoch sein kann.
e) Untersuchungen von St reinfl ssen
Die HPLC-Methode wurde durch die gepr ften Verbindungen nicht gest rt, w hrend die gaschromatogra-
phische Methode manchmal unter berladungsproblemen litt. Die Pisano- und die Bio-Rad-Methode
zeigten die h ufigsten St rungen durch die gepr ften Substanzen.
Schlu folgerung: HPLC und Gaschromatographie sind zur Bestimmung von 3-Methoxy-4-hydroxymandeU
s ure vorteilhafter als die anderen drei Methoden. Vom analytischen Standpunkt ist die HPLC die Methode
der Wahl zur Bestimmung von 3-Methoxy-4-hydroxymandels ure im Harn.
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23, 27—29) and sometimes a two diinensional paper
Chromatographie method (18, 19). In merely half of
the cited articles imprecision data are given (10—12,
14, 15, 20, 23, 25, 27-29). With the exception of
I.e. (25), these articles fail to present imprecision da-
ta of the classical vanilmandelic acid method when a
split sample comparison was carried out. This lack of
quality control and split sample comparison data
make it difficult to compare different 3-methoxy-4-
hydroxymandelic acid methods. Therefore we made
a comparison, including these items, between two
modern 3-methoxy-4-hydroxymandelic acid proce-
dures (the GLC catecholainine metabolite profiling
method described by Muskiet et al. (14) and a modi-
fication by Moleman & Borstrok (30) of the HPLC
method of Morrisey & Shihabi (23)), two classical 3-
methoxy-4-hydroxymandelic acid determinations
(the method of Pisano et. al. (7) and an one dimen-
sional paper Chromatographie procedure compara-
ble with the method described by Vahidi (31)) and
one commercially available 3-methoxy-4-hydroxy-
mandelic acid test (the Βίο-Rad VMA by Column
Test).
It is known that for a urinary 3-methoxy-4-hydroxy-
mandelic acid determination the patient must keep
to a certain diet and stop medication. Therefore we
were also interested in establishing the influence of
various compounds which are known to interfere in
the different methods in a methodological way, ac-
cording to the compilation of Young et al. (32). This
investigation together with the comparison study was
carried out by mailing urine samples to five different
laboratories, each performing one of the five meth-
ods mentioned above and having sufficient expe-
rience with this method.
Materials and Methods
The following chemicals, 3-methoxy-4-hydroxymandelic acid
Standard, control urine and urine samples were used for preparing
different samples of the comparison study.
Chemicals
4-Hydroxy-3-methoxymandelic acid (vanilmandelic acid, VMA),
4-hydroxy-3-methoxyphenylacetic acid (homovanillic aeid,
H V A), p-hydroxymandelic acid, 4^hydroxy-3-methoxybenzoic
acid (vanillic acid) and salicyluric acid were purchased from Sigma
Chemical Co., St. Louis, M.O. 63178.
2,5-Dihydfoxybenzoic acid (gentisic acid), p-aminosalicylic acid,
5-hydroxy-ind leacetic acid; glycerylguaiacolate and tetrabromo-
phenolsulphonephthalein (Bromthalein) were from Merck,
Darmstadt, FRG.
2,5-Dihydroxyphenylacetic acid (homogentisic acid) and phenol-
sulphonephthalein were from Fluka AG, CH-9470 Buchs, Swit-
zerland.
3,4-Dihydroxyphenylacetic acid was from Labkemi, Stockholm,
Sweden.
3 - M e t h o x y - 4 - h y d r o x y m a n d e l i c acid S t a n d a r d
A 100 μπιο1/1 Standard was prepared in 0.05 mol/1 hydrochloric
acid solution and in part diluted to 50 μπηοΐ/ΐ with 0.05 mol/1 hy-
drochloric acid solution.
Control u r i ne
The lyophilized control urine I (lot. No. 090V02) and control
urine II (lot. No. 1V214) both from Ortho Diagnostic Inc. Rari-
ton, New Jersey 08869, were reconstituted with distilled water. A
mixture of 30 vials of control urine I and 9 vials of control urine II
was aliquoted and stored at -20 °C. This mixture was used s a
control urine.
U r i n e samples
All urine samples, collected after the patients had kcpt to a diet
(no coffee, tea, cola drinks, bananas, vanillin and products fla-
voured with vanillin) were preserved by acidification to pH 1.0
with hydrochloric acid. The samples were aliquoted and stored at
-20 °C until they were distributed.
Sample d i s t r i b u t i o n
During a six month period we distributed by mail every two weeks
a series of urine samples. In total 12 series containing 106 samples
were distributed. The urine samples in each series were random-
ized using a table of permutations. On arrival the thawed samples
were stored at 4 °G when the 3-methoxy-4-hydroxymandelic acid
determination could be performed within two days. Otherwise
the samples were frozen.
Imprecis ion s tudy and spl i t sample compar ison
Twelve different urine samples were divided in two groups of six
samples. Each group, completed with two samples of the control
urine, was distributed four times, resulting in eight series. The re-
sults of these sixtyfour 3-rnethoxy-4-hydroxymandelic acid deter-
minations, four determinations in twelve different urine samples
and eight determinations in duplicate of the control urine, were
used for the split sample comparison and the imprecision study.
L i n e a r i t y check
Linearity was checked with a series of nine samples, consisting of
a urine with a low (± 10 μπιοΐ/ΐ) and one urine with a high (± 100
μπιοΐ/ΐ) 3-methoxy-4-hydroxymandelic acid content and mixtures
of these two urines having high/low ratios (by volume) of 1/7, 2/6,
3/5, 4/4, 5/3, 6/2 and 7/1.
Recovery s tudy
For the recovery study the same urine sample with a low content
from the linearity check was enriched with the following 3-me-
thoxy-4-hydroxymandeIic acid concentrations: 20,40, 60, 80 and
100 μπιοΐλ urine.
In t e r f e rence s tudy
A pool urine was aliquoted and to separate aliquots one of the
following compounds was added per liter of pool urine: 2000 mg
of homogentisic acid; 1000 mg of gentisic acid, homovanillic acid,
vanillic acid, salicyluric acid, glycerylguaiacolate, p-aminosalicyl-
ic acid; 500 mg of 3,4-dihydroxyphenylacetic acid, 5-hydroxyin-
doleacetic acid; 100 mg of p-hydroxymandelic acid; 6 mg of phe-
nolsulphonephthalein;35()mg of Bromthalein.
The GLC method
Single determinations were pcrformed with the method according
to Muskiet et al. (14), with the following modifications:
a) after injection the gas Chromatograph was programmcd from
120 °C to 200 °C at 16 °C/min followed by 3 °C/min to 260 °C
and 15min at 260 °C,
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b) 0.25 ml of n-alkane Qs solution (0.5 mmol/1 hexane) was
added to the urine sample before the extraction with ethyl ace-
tate, s a check for the efficiency of the derivatization of the
internal Standard propylgallate.
The HPLC method
The HPLC method was a modification by. Moleman & Bor·
strok(3Q) of the procedure of Morrisey & Shihabi (23). The fol-
lowing alterations were applied:
a) l ml of urine was diluted with l ml of l mol/1 citric acid, con-
taining 5 g EDTA and 5 g Na2S2O.s per litre and extracted with
8 ml of ethyl acetate; the ethyl acetate layer was extracted with
4 ml of 0.1 mol/1 Na2HPO4 pH 8.5, containing 5 g EDTA and
5 g Na2S2C>5 per litre; after removing the ethyl acetate 50 μΐ of
700 g/kg HClO-i was added;
b) 50 μΐ of the acidified phosphate extract was injected;
c) for elution a linear gradient from 2.5 ml to 47.5 ml propanol in
l litre 0.05 mol/1 Na2HPO4 (pH 2.7 with HC1O4) in 10min
was used with a flow rate of 2 ml/min; the reequilibration time
was 5 min;
d) the oxidation potential was maintained at H-0.8 V vs. Ag/
AgCl;
e) quantification was performed by constructing a calibratioii
curve using four 3-methoxy-4-hydroxymandelic acid concen-
trations in the r nge of 10—100 μπιοΐ/ΐ, after the extraction
described under modification a), based on calculation by area.
The following equipment was used: automatic liquid Chromato-
graph with an autosampler and integrator (Hewlett-Packard
1084 B or Spectra Physics 8100-4100) with an electrochemic l
detector (Bioanalytical Systems), consisting of an LC—4 Control-
ler and a TL-5 cell (glassy carbon electrode and Ag/AgCl refer-
ence electrode). The sensitivity was set at 50 nA/V. A filtering of
2 s was used. An analytical column, 15 cm x 4.6 mm I.D.^packed
with Hypersil ODS, 5 μπι particle size, was obtained from Chrom-
pack, Middelburg, The Netherlands. The eluents were filtered
through Millipore filters of pore size of 0.45 μηι and continuously
degassed with helium. The detector response (peak area) and the
retention time were calibrated every six samples with a 3-meth-
oxy-4-hydroxymandelic acid Standard solution injected directly
into the Chromatograph. All determinations were performed in
duplicate.
In this way it is possible to analyse 30 to 40 urine samples in dupli-
cate in 24 hours.
The lifetime of the reference electrode and the analytical column
are about two years. The number of plates are halved during these
two years by several thousand determinations.
The Pisano method
The method of Pisano et al. (7) was performed with one slight
modification: all volumes (starting with 2.5 ml of urine) were re-
duced by half, with the exception of the volumes of the reagents
used for the oxidation with NaIO4, the reduction with Na2S2O5
and the rieutralization with acetic acid and phosphate buffer. The
method was performed in duplicate with regard to the unknown;
the urine blanks were single determinations.
The Bio-Rad V M A by Co lumn Test
The Bio-Rad VMA by Column Test was performed according to
the manufacturer's instructions (33). Only with the determination
of the 3-methoxy-4-hydroxymandelic acid Standard the concen-
tration of Na2S2O5 was 20 times higher than normal. All urine
samples were analysed in duplicate. At the end of this comparison
study the Bio-Rad VMA by Column Test was no longer available,
because of production problems.
The one d imens iona l paper Chromatographie method
The one dimensional paper Chromatographie method was deve-
loped by Molenaar ( Department of Chemical Pathology, Univer-
sity of Leiden, The Netherlands) (34) and is comparable with the
method .published by Vahidi et al. (31).
Stat is t ics
Performing two determinations with the control urine, both in du-
plicate, in the same series, ofi eight diffefent days, we have the
following sources of variance:
o d ' the variance between the eight days (with seven degrees of
freedom)
oid: the variance within each day, between the two determina-
tions (with eight degrees of freedom)
olu: the variance within each day, between the sixteen duplicates
(with sixteen degrees of freedom)
We obtained these variances with a two way of three way variance
analysis (35) and calculated the within^run and between-days
coefficient of Variation s follows:
within-run CV =
mean
(if n = 8 :
8 times l determination in duplicate on the same day)
between-days CV =
oBd + dwd + ->roa
mean
x 100 (%)
(if n = 8 :
l determination in duplicate on 8 days).
Results
Standardiza t ion
Table l shows the values found for the two distrib-
uted 3-methoxy-4-hydroxymandelic acid Standards,
when each method was performed sing its own
standard(s) for quantification.
Imprecision s tudy
The results of the between-days imprecision and the
within-run imprecision of the five methods are given
in table 2. Also the estimates of the variances of
three different s urces (between-days d§d, within-
days between-determinations dwd and within-days
between-duplicates ddu) are shown. ddu of the GLC
method is not known, because this method was not
performed in duplicate.
Linear i ty check
The results of the linearity check are presented in
table 3 s linear regression equations, together with
the number of samples (n) and the correlation coeffi-
cient (r).
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Tab. 1. Values found for two 3-methoxy-4-hydroxymandelic acid
Standards by thc five methods.
3-methoxy-4-hydroxymandelic acid (μπιοΐ/l) found
μπιοΙ/1 GLC Bio-Rad Pisano Paper- HPLC
Standard chromatography
50
100
46.8*) 53.4
87.8*) 99.2
50.4
103.6
46.0
96.0
48.5
100.3
*) The Standards are taken through the entire analytical proce-
dure and calibration is done with a Standard not taken through
the entire procedure.
Recovery
In table 4 the results of the recovery experiments are
shown. The mean analytical recovery ± l SD, to-
gether with the results of the linear regression analy-
sis, are given.
Split sample compar ison
Figures l a—d give the results of the comparison of
the 3-methoxy-4-hydroxymandeIic acid concentra-
tions found in thirteen urines with all five methods.
Tab. 2. Results of imprecision study with the five methods (n = 8)
3-methoxy-4-hydroxymandelic acid
mean (μπιοί/)
d u
„ T
id
or«l;t,
Within-runCV(%)
Between-days CV (%)
GLC
20.0
-
1.12
6.50
7.62
5.3
13.8
Bio-Rad
32.4
0.63
2.41
0.94
3.66
5.1
5.9
Pisano*)
23.2 (24.6)
0.60 (0.60)
11.22 (1.65)
3.67 (0.31)
15.19 (2.26)
14.6 (5.7)
16.8 (6.1)
Paperchromatography
30.0
2.36
5.63
5.81
12.62
8.7
11.8
HPLC
24.5
0.24
0
2.01
2.13
1.4
6.0
*) Results between brackets are corrected for too high urine blanks.
Tab. 3. Results of the linearity check with the five methods.
For the linear regression analysis: χ = l is the low. χ = 9
is the high urine sample (see Materials and Methods un-
der linearity check); y is the amount of 3-methoxy-4-hy-
droxymandelic acid found by the five methods; n is the
number of urine samples; r is the correlation coefficient.
Method
GLC
Bio-Rad
Pisano
Paperch ro mat ograph y
HPLC
Linear regression line
y=- l . l+ -8.12 χ
y=.11.0+ 9.95 χ
y = 1.2 4- 10.71 χ
y = -2.0+ 12.54 χ
y . = -3.7 -Hl 1,78 χ
n
8
9
9
9
9
r
0.9944
0.9943
0.9993
0.9959
0.9987
Twelve urines were analysed four times and one
urine (the control urine of the imprecision study)
was analysed sixteen times (eight times in duplicate).
The means of these values were used for the linear
regression analysis. The results are given with the
HPLC method selected s the reference method, be-
cause of the good results of the imprecision, lineari-
ty, recovery and interference study (see Discussion).
In table 5 we summarized different linear regression
lines (no. 1—12), obtained by varying the reference
method (HPLC or Pisano method) and the concen-
tration unit of 3-methoxy-4-hydroxymandelic acid
Tab. 4. Results of the recovery study with the five methods.
A urine with low 3-methoxy^44iydroxymandelic acid content was enriched with the following 3-methoxy-4-hydroxymandeIic
acid concentrations: 20, 40, 60, 80 and 100μπκ>1/1 urine.
For the linear regression analysis: χ is the added arnount of 3-methoxy-4-hydroxymandelic acid; y is the amount of 3-methoxy-4-
hydroxymandelic acid found by the five methods; n is the number of urine samples; r is the corrclation coefficient.
Method
GLC
Bio-Rad
Pisano
Paperchromatography
HPLC
Mean recovery ± 1 SD
95.7 ± 9.1
96.0 ±3.3
94.4 ± 2.1
93,9 ± 2.6
101.3 ± 1.3
Linear regression line
y = 6.8 4- 0.98 χ
y = 15.0 + 1.00 χ
y = 6.6 + 0.98 χ
y = 10.2 -h, 0.94 χ
y = 7.5+ 1.01 χ
n
6
5
6
6
6
r
0.9932
0.9993
0.9981
0.9990
0.9994
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(μηιοΐ/ΐ or μιτιοΙ/24 h) and by correcting for the re-
covery differences. We also give four linear regres-
sion lines found in the literature (no. 13—16).
80
70
60
i 50
S 40
£30
20
10
l
Ο 10 20" 30 40 50 60
3-Methoxy-4-hydroxymondel ic acid ( H P L C ) l / imol/ l]
Fig. l a. Linear regression analysis:
y(Bio-Rad)= 14.5-f 0.83x (HPLC); n = 11; r = 0.9829.
In ter ference s tudy
The in vitro influence of twelve compounds on the
five methods are presented in table 6. The results re
the mean of two determinations.
70
60
o
l 50
30
20
10
l \ \ \
0 10 20 30 40 50 60
3-Methoxy-4-hydfoxymqnde l ic ocid ( H P L C ) [ μίτιοΐ/ΐ]
Fig. Ib. Linear regression analysis:
y(Pisano) = 3.5 + 0.84 χ (HPLC); n = 12; r = 0.9912.
0 10 20 30: 40 50 60
3-Methoxy-4-hydroxymqndelit ucid ( H P L C ) i/imo:l/l]
Fig. Id. Linear regression analysis:
y(GLC) = 1.6 + 0.85x (HPLC); n = 12; r = 0.9929.
'" 0 10 20 30 40 50 60
3-Methoxy-4-hydroxymandelic acid ( H P L C ) l/imol/l]
Fig. Ic. Linear regression analysis:
y(Paperchromatography) = 3.9 + 1.07χ (HPLC); n
- 12; r = 0.9912.
Fig. la-d. Split sample comparison between the five methods with the HPLC method s reference method (x-axis).
Dashed line represents the line y = x; Solid line represents the linear regression line.
O mean of 4 determinations
D mean of 16 determinations (control urine)
x sample omitted for the linear regression analysis. v *
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Tab. 5. Linear regression lines obtained with the comparison study and by varying the refercncc mcthod and the concentration unil and
by correcting for recovery differences, together with four resulls from the literature.
No.
1
2
3*)
4
5
6*)
7
8
9
10*)
11
12*)
13
14
15
16
Linear regression line
y (Bio-Rad)
y (Pisano)
y (Pisano)
y (Pap.chr.)
y(GLC)
y (GLC)
y(GLC)
y (GLC)
y (HPLC)
y (HPLC)
y (HPLC)
y (HPLC)
y (GLC)
y (GLC)
y (HPLC)
y (HPLC)
=
==
β
ss
SS
SS
s=
ss
SS
ss
SS
s
=
SS
=
—
14
3
3
3
1
1
-1
-2
-3
-3
-3
-3
21
2
0
0
.5
.5
.7
.9
.6
.7
.9
.2
.6
.6
.3
.2
.7
.63
.61
.36
+ 0.83 χ
+ 0.84x
+ 0.91 χ
+ 1.07 χ
+ 0.85 χ
+ 0.90 χ
+ 1.01 χ
+ 0.96 χ
+ 1.16x
+ 1.08 χ
+ 1.04 χ
+ 0.97 χ
+ 0.62 χ
+ 1.05 χ
+ 1.06 χ
+ 0.99 χ
(HPLC)
(HPLC)
(HPLC)
(HPLC)
(HPLC)
(HPLC)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
(Pisano)
n
11
12
12
12
12
12
13
11
12
12
10
10
224
65
41
20
r
0
Concentration unit Referencc
.9829
0.9912
0
0
0
.9912
.9957
.9927
0.9927
0
0
0
0
0
0
0
0
0
0
.9959
.9650
.9912
.9912
.9259
.9267
.844
.997
.997
.931
μτηοΐ/ΐ
μιηοΐ/ΐ
μηιοΙ/1
μπιοΐ/l
μηιοΐ/l
μηιοΙ/1
μηιοΙ/1
μηιοΙ/24 h
μιηοΐ/ΐ
μηιοΐ/ΐ
μηιοΙ/24 h
μηιοΙ/24 h
μηιοΐ/ΐ
μπιοΙ/24 h
μπιοΐ/ΐ
μπιοΙ/24 h
thisarticlc
thisarticle
this article
this article
this article
this article
thisarticle
thisarticlc
thisarticlc
this article
this article
this article
(10)
(15)
(22)
(27)
*) corrected for differences in recovery (see tab. 4).
Tab. 6. Results of the interference study with five methods.
Interfering compound
None
3,4-Dihydroxyphenylacetic acid
Homovanillic acid
p-Hydroxymandelic acid
Vanillic acid
Salicyluric acid
Gentisic acid
Homogentisic acid
p-Aminosalicylic acid · ] *
5-Hydroxyindoleacetic acid [
Glycerylguaiacolate J
Phenylsulphonephthalein 1*
Bromthalein /
3-Methoxy-4-hydrodroxymandelic acid (μιποΐ/ΐ)
Concentration GLC Bio-Rad Pisano Paper- HPLC
(mg/1) chromatography
-
500
1000
100
1000
1000
1000
2000
1000
500
1000
6
350
14.9
a
14.8
15.2
14.8
13.2
16.6
b
c
13.7
44.3
13.0
136.9
249.9
46.3
45.4
47.0
43.6
40.8
and
70.3d
43.1
25.9
21.3 -
9.2C
52.8
26.7
27.2
6.2
5.6
21.4
27.5
27.7
28.2
28.4
27.4
31.0
26.7
25.6
23.0
41.8
29.8
23.4
26.4
24.8
23.4
26.2
23.8
24.8
23.5
26.2
27.8f
21.3*
23.6
*: mixtures of these compounds were added to an aliquot of the pool urine.
a, b: the interfering compound was not separated from 3-methoxy-4-hydroxymandelic acid, because of their large difference in concen-
tration.
c: 5-hydroxyindoleacetic acid was not separated from the internal Standard propylgallate, because of the large difference in concen-
tration between 5-hydroxyindoleacetic acid and propylgallate.
d: this difference could not be investigated because the Bio-Rad VMA by Column lest was no longer
available.
e: 500 mg homovanillic acid gave a result of 7.7 μιηοΐ/ΐ 3-methoxy-4-hydroxyrnandelic acid.
f: 3rmethoxy-4-hydroxymandeIic acid'was not fully separated from an impurity in the homogentisic acid preparation.
g: 5rhydroxyindoleacetic acid (eluting after 3-methoxy-4-hydroxymandelic acid, without interfering) deteriorated the electrode
surface, result i ng in a decreased detector response for the subsequent analysis.
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Discussion ical chemical laboratories in the Netherlands, P. J.
. ,, Brombacher (37), including laboratories using the
Table l shows that differences between the 3- ^
 p^ method
methoxy-4-hydroxymandelic acid concentrations
found by the five methods in the same urine sample jhe results of the between-days imprecision of the
cannot be attributed to differences in standardiza- different methods are given in table 7r. Laboratories
tion, except for the GLC method. The results of the
 nos. g, 7 and 8 performed the Pisano, the Bio-Rad
GLC method indicate that the mean recovery was
 an(j the paper Chromatographie method, respectively
90.7%, so all results should be corrected with this jn the comparison study. Table 6 shows that the
percentage. This was only done with the results of
 mean Value of the control urines (aliquoted urine
the linearity check, the recovery and the comparison
 pOols, stored at -20 °C) is almost the same f r la-
study. boratories nos. 1—6, but the ranges of the between-
The results of the imprecision study (tab. 2) indicate days CV are broad. Both imprecision data, cofrected
that the within-run and between-days imprecision of and uncorrected, He between these ranges, but even
the two classical methods are large compared with the corrected CV is two times higher than that of
the other three methods. In the paper chromato- lab ratory 6 in table 7.
eraohic method, this may be due especially to the . . .
sTm'etimes non-^ptimal Separation of 3-metL*y-4- Pnly the correctedresults of the ™V^^*
hydroxymandelic acid from very faint coloured spots the Pisano method are comparable with the resujts
of unknown compounds. The high coefficient of va- of Wmer & Stamm (36)'
riation of the Pisaho method is mainly due to diffi-
 The between-days CV of the GLC method is high.
culties in determining the urine blanks. In three out
 This can be explained by the following facts. The
of eight series, we found that the absorbance of the
 GLC method, not performed in d plicate like the
urine blanks of the contr l urine were higher than
 othefs, is not only a method for the determination of
normal. If a correction is made with the use of a 3^methoxy-4-hydroxymandelic acid, but also of ho-
mean urine blank value, we get the imprecision data movanillic acid, 3-methoxy-4-hydroxyphenylethy-
placed between brackets in table 2. The imprecision
 lene gjyco^ 3,4-dihydroxyphenylacetic acid and 5-
data are now comparable with those of the Bio-Rad, hydroxyindoleacetic acid. This meaiis that the ana-
the HPLC and the GLC (only within-run CV) meth- ,ytical concijtions are not optimally chosen for the
ods. The reason for these variations, especially in the
 determination of 3-methoxy-4-hydroxyniandelic
urine blank, is unknown.
 add; the between-days CV of 3-methoxy-4-hydroxy-
In the literature we could find data on the impreci- mandelic acid is always higher if the method kicludes
sion of the Pisano method from only one group of an enzymatic hydrolysis, like the one iiecessary for
investigators: Wisser & Stamm (between-days the determination of 3-methoxy-4-hydroxyphenyl
CV = 4.8%; n = 48; χ = 18 μπιοΐ/ί; within-run ethylene glycol, the between-days CV found for 3-
CV = 1.6%; n = 48; χ = 18 μπιοΐ/l) (36). They used methoxy-4-hydroxymandelic acid is in good agree-
a modified Pisano method for aliquoting the organic ment with that given by Muskiet et al. in their origi-
extraction solvents. Therefore we also compared our nal article (14) (CV == 14.3%; n = 20; χ = 1.6
results with data from a quality control group of clin- mm l/mol creatinine).
Tab. 7. Between-days CV of the 3-methoxy-4-hydroxymandelic acid determination in two aliquoted urine pools stored at -20 °C of 8
laboratories participating in a quality control group in the Netherlands, P. J. Brombacher (37).
No.
1
2
3
4
5
6
7
8
Method
Pisano
Pisano
Pisano
Pisano
Pisano
Pisano
Bio-Rad
Paperchromatography
n
22
18
17
19
8
6
31
30
X
(μηιοΐ/ΐ)
34
35
35
41
33
34
46
33
SD
(μΠΊθΙ/1)
6.6
2.2
2.9
4.6
4.9
1.0
3.4
3.1
CV(%)
19.5
6.4
8.2
11.0
15.01
2.9
7.4
9.3
n
21
18
16
18
8
6
31
30
X
(μπιοΐ/l)
17
14
15
18
14
13
22
15
SD
(μηιοΐ/ΐ)
3.7
1.3
1.5
2.0
1.4
0.4
2.4
2.4
CV(%)
22.6
.9.3
9.6
11.0
9.8
3.2
10.6
15.7
Lab ratory nos. 6, 7 and 8 are the same laboratories participating in this comparison study.
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The imprecision data of the Βίο-Rad and the HPLC
method are excellent. The within-run CV of the
HPLC method is extremely low (1.4%). Also for the
Bio-Rad method a comparison of the imprecision
data can only be made with the results of table 7
(laboratory no. 7), showing that the between-days
CV is somewhat smaller in our comparison study.
Of those HPLC methods reporting quality control
data, only the between-days imprecision of the
HPLC method with a periodate oxidative monitor
(CV = 5.7 and 6.1%; χ = 25.0 and 34.5 μπιοΙ/1;
n = 8 (28)) is comparable with our results. All other
HPLC methods (21, 25, 27 and 29) and even the
method of Morrisey & Shihabi (CV = 7.8%;
x = 70.0 μιυοί/ΐ; n = 19 (23)), which was modified,
show quality control data with larger imprecision
than the HPLC method used in this study.
Moleman & Borstrok (32) publish the following data
of their own routine quality control: within-run CV:
3.0; 4.1; 2.0%; between-days CV: 6.5; 4.9; 5.0%;
n = 10; 11; 11; χ = 10.8; 43.2; 74.8 μπιοΐ/ΐ. These
excellent imprecision data are achieved by the modi-
fied sample clean up and by calibrating the detector
response and the retention time every six samples.
The results of the linearity check (tab. 3) show a
good linearity for all five methods (r ranging from
0.9943-0.9993). However the slopes and the inter-
cepts of the five regression lines are quite different.
This means a difference in accuracy between the five
methods. In order to investigate whether these dif-
ferences were due to recovery problems, the same
urine sample with low 3-methoxy-4-hydroxyman-
delic acid content was enriched with known quanti-
ties of 3-methoxy-4-hydroxymandelic acid. The re-
sults of these recovery studies, presented in table 4,
also show a good linearity for all methods (r ranging
from 0.9931-0.9994). The mean recovery found
with the GLC (95.7%), the Pisano (94.4%), the
Bio-Rad (96.0%) and the paper Chromatographie
method (93.9%) are almost equal. The mean recov-
ery found with the HPLC method (101.3%) is some-
what better than the data obtained with the other
.methods. The HPLC method also shows the smallest
Standard deviation. These small differences in reeov-
ery cannot be responsible for the deviations found in
the slopes and intercepts of the regression lines in
table 3. Thus, we conclude that the accuracies of the
five methods are unequal because of differences in
the contribution of urinary compounds other than 3^
methoxy-4-hydroxymandelic acid to the determina-
tion of 3-methoxy-4-hydroxymandelic acid.
This conclusion is also visualized in the figures l a—d
presenting the results of the split sample comparison
study. Figure l a clearly shows that the Bio-Rad
method gives higher values, especially in the low
concentration r nge. Sometimes the discrepancy is
very large: in one urine sample the HPLC method
gives a 3-methoxy-4-hydroxymandelic acid value of
38.5 μπιοΙ/Ί and the Bio-Rad method gives a value of
73.4 μιηοΙ/1 (mean of four determinations). This
means that the contribution to the 3-methoxy-4-hy-
droxymandelic acid determination of other com-
pounds in urine is very large and may vary from
urine to urine. We did not clarify the nature of these
compounds.
Figure l b and l d show that the correlation between
the GLC, Pisano and HPLC method is reasonable
(r = 0.9912 and 0.9929 respectively). Both the GLC
and the Pisano method give higher values in the high
concentration r nge. Even after correction for the
recovery differences (see tab. 4), the Pisano method
(values above 40 μπιοΐ/ΐ) and the GLC method
(values above 17 μπιοΐ/ΐ) still give lower 3-methoxy-
4-hydroxymandelic acid values than the HPLC
method (see also the linear regression lines no. 3 and
6 in table 5).
Taking the Pisano method s reference method, our
split sample comparison results with the GLC meth-
od (linear regression line no. 7 in table 5) are better
than those of Addanki et al. (linear regression line
no. 13). Our results are in reasonable agreement
with the results of Leiendecker-Foster & Feier (see
linear regression lines nos. 8 and 14).
The results of Felice & Kissinger and of Bauersfeld et
al., comparing their HPLC method with electro-
chemical detection with the Pisano method s refer-
ence method (linear regression lines nos. 15 and 16
respectively in table 5) correlate well with our linear
regression lines nos. 10 and 12 respectively.
The correlation between the paper Chromatographie
method and the HPLC method is the best of all four
comparisons (r = 0.9957). However the results of
the paper Chromatographie method are always
higher than those of the HPLC method, but the dif-
ferences are smaller than with the Bio-Rad method.
In our own laboratory we made a more extensive
comparison study between the HPLC and the paper
Chromatographie method using 101 urine samples.
This study resulted in almost the same linear regres-
sion line: y(paperchrom.) = 3.8 H- 1.07 χ (HPLC),
but with a poorer correlation coefficient: r = 0.9162.
We have taken the HPLC method s reference
method for the split sample comparison study be-
cause of the good results of the imprecision, lineari-
ty, recovery and interference study. However, s can
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be seen in figures l a-d the 3-methoxy-4-hydroxy-
mandelic acid content of one urine sample indicated
with X is overestimated by the HPLC method
(14.8 μπιοΙ/1) compared with the other four methods
(6.2—12.1 μητοΐ/ΐ). This was due to an unknown
compound not fully separated from 3-methoxy-4-
hydroxymandelic acid.
Compounds which are known to interfere in differ-
ent 3-methoxy-4-hydroxymandelic acid methods are
found in the compilation of Young et al. (32). Such a
compound can cause an in vivo interference because
it intervenes in the catecholamine metabolism or a
methodological interference. The physiological in-
terference is of no interest in the comparison of 3-
methoxy-4-hydroxymandelic acid methods, so we
only studied the methodological interferences. To
aliquots of a pool urine, we added those compounds,
which, according to the literature, are the real meth-
odological interfering compounds. The amount of
each interfering cbmpound added to aliquots of the
pool urine was largely based on abnormal levels seen
in some disorders.
The results of the interference study (tab. 6) show
that the HPLC method is the only method free of
interference from the compounds tested. Only 5-hy-
droxyindoleacetic acid caused some detector prob-
lems due to the high concentration, resulting in loss
of. response. The GLC method sometimes has only
Separation problems due to too large a difference in
concentration between the interfering compound
and 3-methoxy-4-hydroxymandelic acid or the inter-
nal Standard. In cases of pathological increases of
3,4-dihydroxyphenylacetic acid or 5-hydroxyindo-
leacetic acid, such problems are not encountered, s
shown by the gas chromatograms of urines from pa-
tients with neuroblastoma and carcinoid tumour in
figure 2 of I.e. (14). Only an elevation of homogen-
tisic acid in patients with alcaptonuria could perhaps
give some problems in determining 3-methoxy-4-hy-
droxymandelic acid. The paper Chromatographie
method is only influenced by p-aminosalicylic acid,
which produces an elevated background after stain-
ing. Correction with a blank including this elevated
background prevents falsely elevated 3-methoxy-4-
hydroxymandelic acid results.
The Pisano and the Βίο-Rad method are rnost sensi-
tive for the interfering compounds tested. The influ-
ence of these compounds on the Pisano method,
mentioned in table 6, are in agreement with the re-
sults of Feldman et al. (38) and Pisano et al. (7). We
did not find the deereasing influence of 3,4-dihy-
droxyphenylacetic acid s reported by Feldman et al.
Whether the increase of the 3-methoxy-4-hydroxy-
mandelic acid levels obtained by the Bio-Rad meth-
od caused by the addition of homovanillic acid and
p-hydroxymandelic acid, and the decrease of the lev-
els due to the addition of 3,4-dihydroxyphenylacetic
acid, are relevant at more physiological concentra-
tions could not be investigated because the Bio-Rad
method was no longer available.
If we compare all methods studied, we can conelude
that from an analytical point of view the HPLC and
the GLC method are superior to the other three
methods. Our final conclusi n is that the HPLC
method is the best method of choice for determining
3-methoxy-4-hydroxymandelic acid in urine, be-
cause of the better results of the impfecision study.
However this larger impreeision of the 3-methoxy-4-
hydroxymaiidelic acid determination of the GLC cat-
echolamine metabolite profiling method is compen-
sated by the determination of more than one cat-
echolamine metabolite. So it is possible that from a
diagnostical point of view this HPLC method, deter-
mining only 3-methoxy-4-hydroxymandelic acid,
will not be the method of choice. This problem of
determining one metabolite very precisely or more
metabolites with larger imprecision, which is possi-
ble with GLC (14) and HPLC (26) methods, must be
the subject of further clinical chemical research.
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